Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial

INTRODUCTION: Atacicept is a soluble, fully human, recombinant fusion protein that inhibits B cell-stimulating factors APRIL (a proliferation-inducing ligand) and BLyS (B-lymphocyte stimulator). The APRIL- LN study aimed to evaluate the efficacy and safety of atacicept in patients with active lupus...

Descripción completa

Detalles Bibliográficos
Autores principales: Ginzler, Ellen M, Wax, Stephen, Rajeswaran, Anand, Copt, Samuel, Hillson, Jan, Ramos, Eleanor, Singer, Nora G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392829/
https://www.ncbi.nlm.nih.gov/pubmed/22325903
http://dx.doi.org/10.1186/ar3738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392829/
https://www.ncbi.nlm.nih.gov/pubmed/22325903
http://dx.doi.org/10.1186/ar3738

Ejemplares similares